STAT · Scour

STAT+: In court, AAP argues Kennedy’s HHS made unlawful changes to vaccine policies

statnews.com·1d

STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher

statnews.com·1d

Major shakeup underway at HHS as White House braces for midterms

statnews.com·1d

STAT+: Up and down the ladder: The latest comings and goings

statnews.com·1d

STAT+: Pediatricians confront HHS in vaccine showdown

statnews.com·1d

STAT+: Pharmalittle: We’re reading about Lilly bulking up on weight-loss drugs, scrutiny of a 340B contractor, and more

statnews.com·1d

HHS shakes ups key advisers

statnews.com·1d

Opinion: Pharmacist oversight must be built into prescription kiosks

statnews.com·1d

Opinion: America’s disease surveillance system is going dark. Here’s what we can build to replace it

statnews.com·1d

STAT+: How pediatricians found themselves at war with RFK Jr.

statnews.com·1d

STAT+: Moderna’s president weighs in on FDA’s decision not to review its flu vaccine

statnews.com·2d

The FDA’s refusal to review Moderna’s mRNA flu vaccine

statnews.com·2d

STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs

statnews.com·2d

STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry

statnews.com·2d·

Discuss: Hacker News

STAT+: The messaging war over Medicaid cuts

statnews.com·2d

STAT+: NIH redefines ‘clinical trials,’ dividing researchers

statnews.com·2d

STAT+: A change at the top of Sanofi

statnews.com·2d

STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more

statnews.com·2d

STAT+: STAT Health Tech: Researchers take another look at Apple’s hypertension feature

statnews.com·2d

STAT+: Big Health raises funding as investors see glimmer of hope for digital therapeutics

statnews.com·2d

Loading more...